The follicle-side complement to GHK-Cu
COSTA.IT 295 trial showed that although pioglitazone had no significant difference in total cardiovascular deaths compared with sulfonylureas in primary ASCVD diabetic patients, it significantly reduced the risk of ischemic cardiovascular events by 33%
(PubMed) Suksomboon N, Poolsup N, Juanak N
Should you test positive for this gene variation, and find that you do indeed have issues relating to methylation, I recommend taking Rootcology MTHFR Pathways , as it contains ingredients (riboflavin, B6, methyl folate, B12, trimethylglycine, and L-serine) that support the metabolism of homocysteine and help maintain healthy homocysteine levels.* In my 2015 survey, 45 percent of people with Hashimotos said they felt better after adding methylation-supporting supplements to their regimen